Patent details

EP3518962 Title: SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE

Basic Information

Publication number:
EP3518962
PCT Application Number:
US2017053961
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177914850
PCT Publication Number:
WO2018064303
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE
French Title of Invention:
SEBELIPASE ALFA POUR LE RÉDUCTION DE LA FIBROSE HÉPATIQUE ET DU TRAITEMENT D'UN DÉFICIT EN LIPASE ACIDE LYSOSOMALE SUR LA BASE D'UN STADE DE FIBROSE D'ISHAK
German Title of Invention:
SEBELIPASE ALFA ZUR REDUZIERUNG VON LEBERFIBROSE UND BEHANDLUNG VON MORBUS WOLMAN AUF BASIS DES ISHAK-FIBROSEGRADS
SPC Number:

Dates

Filing date:
28/09/2017
Grant date:
09/06/2021
EP Publication Date:
07/08/2019
PCT Publication Date:
05/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/06/2021
EP B1 Publication Date:
09/06/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/09/2021
Expiration date:
28/09/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/06/2021
 
 

Name:
Alexion Pharmaceuticals, Inc.
Address:
121 Seaport Boulevard, Boston, MA 02210, United States (US)

Inventor

1

Name:
SONI, Paresh
Address:
United States (US)

2

Name:
QUINN, Anthony
Address:
United States (US)

3

Name:
RANKIN, Andrew
Address:
United States (US)

4

Name:
FRIEDMAN, Mark
Address:
United States (US)

5

Name:
GOODMAN, Zachary
Address:
United States (US)

6

Name:
BURTON, Barbara
Address:
United States (US)

Priority

1

Priority Number:
201662402183 P
Priority Date:
30/09/2016
Priority Country:
United States (US)

2

Priority Number:
201662420233 P
Priority Date:
10/11/2016
Priority Country:
United States (US)

3

Priority Number:
201762456511 P
Priority Date:
08/02/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/46; A61P 1/16; A61P 3/00;

Publication

European Patent Bulletin

Issue number:
202123
Publication date:
09/06/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages